Stryker (SYK) Change in Account Payables (2009 - 2026)
Stryker (SYK) reported Change in Account Payables of -$198.0 million for Q1 2026, up 35.92% year-over-year from -$145.7 million in Q1 2025, and down 166.22% quarter-over-quarter from $299.0 million in Q4 2025.
Stryker (SYK) Change in Account Payables (2009 - 2026) Analysis & Trends
Stryker (SYK) has 18 years of Change in Account Payables data on file, last reported at -$198.0 million in Q1 2026.
- Change in Account Payables for Q1 2026 came in at -$198.0 million, up 35.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $205.0 million (up 46.43% YoY), and the FY2025 annual result was $94.0 million, down 51.04% from the prior year.
- Change in Account Payables slipped to -$198.0 million in Q1 2026 per SYK's latest filing, from $299.0 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $395.0 million in Q4 2024 and troughed at -$309.0 million in Q1 2025.
- A 5-year average of $26.8 million and a median of $40.0 million in 2025 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2024 and 2025: Change in Account Payables slumped 358.93% in 2024, then jumped 3100.0% in 2025.
- A 5-year view of Change in Account Payables shows it stood at $179.0 million in 2022, then gained by 8.94% to $195.0 million in 2023, then surged by 102.56% to $395.0 million in 2024, then declined by 24.3% to $299.0 million in 2025, then sank by 166.22% to -$198.0 million in 2026.
- Business Quant data shows SYK's Change in Account Payables at -$198.0 million in Q1 2026, $299.0 million in Q4 2025, and $64.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -198.00 Mn |
| Mar 31, 2026 | -198.00 Mn |
| Dec 31, 2025 | 299.00 Mn |
| Dec 31, 2025 | 299.00 Mn |
| Sep 30, 2025 | 64.00 Mn |
| Sep 30, 2025 | 64.00 Mn |
| Jun 30, 2025 | 40.00 Mn |
| Jun 30, 2025 | 40.00 Mn |
| Mar 31, 2025 | -309.00 Mn |
| Mar 31, 2025 | -309.00 Mn |
| Dec 31, 2024 | 395.00 Mn |
| Dec 31, 2024 | 395.00 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | 52.00 Mn |
| Jun 30, 2024 | 52.00 Mn |
| Mar 31, 2024 | -257.00 Mn |
| Mar 31, 2024 | -257.00 Mn |
| Dec 31, 2023 | 195.00 Mn |
| Dec 31, 2023 | 195.00 Mn |